Decision vacuum and prepared delegation in cancer end-of-life decision-making: a scoping review.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
Abstract originale
CONTEXT: End-of-life (EOL) decision-making profoundly shapes the quality of dying for advanced cancer survivors and the long-term psychological well-being (e.g., mitigating persistent decisional regret) of their bereaved families. While decision-making styles range from individual autonomy to clinician delegation across clinical and cultural contexts, their structural process determinants remain poorly synthesized. OBJECTIVES: To synthesize international (English-language) and Japanese evidence clarifying how EOL decision-making processes and timing influence psychological and economic outcomes in oncological care. METHODS: Following PRISMA-ScR guidelines, we searched PubMed and Ichushi-Web for studies published from 2016 to 2026. Inclusion criteria focused on advanced cancer decision-making (involvement or delegation) and multi-dimensional outcomes, including psychological (satisfaction, regret, conflict), clinical (aggressiveness of care), and economic outcomes (financial toxicity, healthcare resource utilization). Narrative synthesis was performed on all 136 included studies (detailed matrix provided in Supplementary Table S1). RESULTS: From 1,813 records, 136 studies were included. Physician-led decisions without prior value validation were associated with significantly higher decisional regret (p = - 0.400) and lower quality-of-life evaluations. A lack of preparedness contributed to a clinical "decision vacuum"-a state where unarticulated patient preferences lead to decision-making dictated by external system drivers or paternalism-frequently pushing vulnerable families toward non-evidence-based therapies, resulting in "Financial Toxicity" and inappropriate aggressiveness of care. Three key process moderators-validation of values, information transparency, and multidisciplinary coordination-were identified as essential for transforming delegation into a high-quality, value-concordant process ("prepared delegation"). CONCLUSION: EOL support must transcend the rigid dichotomy between individual autonomy and delegation. Implementing the "prepared delegation" model through early intervention and multidisciplinary validation can eliminate the "decision vacuum," thereby preventing persistent decisional regret and protecting family economic and psychological well-being across the survivorship trajectory.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Decision vacuum and prepared delegation in cancer end-of-life decision-making: a scoping review
Abstract
Context
End-of-life (EOL) decision-making profoundly shapes the quality of dying for advanced cancer survivors and the long-term psychological well-being (e.g., mitigating persistent decisional regret) of their bereaved families. While decision-making styles range from individual autonomy to clinician delegation across clinical and cultural contexts, their structural process determinants remain poorly synthesized.
Objectives
To synthesize international (English-language) and Japanese evidence clarifying how EOL decision-making processes and timing influence psychological and economic outcomes in oncological care.
Methods
Following PRISMA-ScR guidelines, we searched PubMed and Ichushi-Web for studies published from 2016 to 2026. Inclusion criteria focused on advanced cancer decision-making (involvement or delegation) and multi-dimensional outcomes, including psychological (satisfaction, regret, conflict), clinical (aggressiveness of care), and economic outcomes (financial toxicity, healthcare resource utilization). Narrative synthesis was performed on all 136 included studies (detailed matrix provided in Supplementary Table S1).
Results
From 1,813 records, 136 studies were included. Physician-led decisions without prior value validation were associated with significantly higher decisional regret (p = − 0.400) and lower quality-of-life evaluations. A lack of preparedness contributed to a clinical “decision vacuum”—a state where unarticulated patient preferences lead to decision-making dictated by external system drivers or paternalism—frequently pushing vulnerable families toward non-evidence-based therapies, resulting in “Financial Toxicity” and inappropriate aggressiveness of care. Three key process moderators—validation of values, information transparency, and multidisciplinary coordination—were identified as essential for transforming delegation into a high-quality, value-concordant process (“prepared delegation”).
Conclusion
EOL support must transcend the rigid dichotomy between individual autonomy and delegation. Implementing the “prepared delegation” model through early intervention and multidisciplinary validation can eliminate the “decision vacuum,” thereby preventing persistent decisional regret and protecting family economic and psychological well-being across the survivorship trajectory.
Supplementary information
The online version contains supplementary material available at https://doi.org/10.1007/s00520-026-11394-3.
Keywords: End-of-life decision-making, Decision vacuum, Prepared delegation, Decisional regret, Scoping review
Introduction
In contemporary palliative care and oncology, end-of-life (EOL) decision-making is a core process that defines the quality of care and facilitates life completion aligned with patients’ values [1, 2]. With the advances in medical technology, patients and their families are increasingly confronted with complex and ethical decisions, such as the selection of life-sustaining treatments and choices about care settings [3]. Proper decision-making in these scenarios not only preserves the patient’s dignity but has also been demonstrated to have long-term impacts on bereaved family members’ mental health and satisfaction [4, 5].
Against this background, advance care planning (ACP) has been internationally recommended as an essential foundation for facilitating communication among patients, families, and healthcare providers to support shared decision-making (SDM). However, the concepts and implementation of ACP are heavily dependent on medical systems and socio-cultural norms, and the limitations of applying a uniform model have been noted [3, 6, 7].
Decision-making styles exist along a broad spectrum. In much of the international literature, individual autonomy and ACP are emphasized, whereas discussions in Japan and other East Asian settings frequently highlight relational autonomy, family involvement, and trust-based delegation. Recent consensus studies on ACP in Asia underscore that family-centered decision-making and relational harmony are integral to local clinical realities, rather than mere barriers to autonomy [6, 7]. In Japan, the delegation style—often referred to as “omakase”—is frequently selected due to a desire to avoid burdening family members or a high degree of trust in clinicians [3, 8]. While such delegation can reduce the patient’s immediate psychological pressure, it carries the risk of decisions being driven by external circumstances if conducted without adequate dialogue or preparation.
In this study, we define a “decision vacuum” as a state in which explicit patient preferences are not articulated, resulting in decision-making being driven by external factors such as clinician judgment or systemic constraints. This vacuum is associated in the synthesized literature with downstream outcomes, including financial toxicity related to non-evidence-based therapies after the cessation of standard treatment [9, 10] and inappropriate medical-resource use, such as increased intensive care unit admissions and escalating medical costs [11, 12].
Previous discussions of EOL decision-making often contrast autonomy with delegation; however, this dichotomy may obscure the importance of process quality, including whether patient values are clarified, information is transparent, and families receive multidisciplinary support. Furthermore, even in Western settings, ACP implementation often faces barriers such as family conflict and prognostic uncertainty, suggesting that the challenges are not merely cultural but structural. Moreover, existing reviews are heavily biased toward English-language literature, and there is a lack of research that integrates Japanese-language or local evidence with international literature to clarify the clinical realities of non-Western EOL decision-making, including decision-making in Japan.
The objective of this scoping review is to synthesize evidence from both international literature (PubMed) and Japanese literature (Ichushi-Web) databases to systematize the determinants of psychological and economic outcomes in cancer end-of-life decision-making. This review clarifies how decision-making styles, specific topics, supportive interventions, and timing contribute to the satisfaction or psychological burden of patients and families. By integrating these dimensions, we aim to delineate the process-oriented determinates of high-quality decision-making and establish a clinically actionable framework that mitigates the “decision vacuum” across diverse healthcare contexts.
Methods
Design and guidelines
This study was conducted as a scoping review to systematically synthesize existing knowledge on end-of-life decision support and to construct an integrated framework for psychological outcomes. The review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines to ensure transparent and rigorous reporting.
Search strategy and information sources
To capture both international literature and Japanese clinical evidence, a systematic literature search was performed across two major databases: PubMed and Ichushi-Web (Japan Medical Abstracts Society database). This dual-database strategy was used to reduce reliance on English-language literature when examining Japanese EOL decision-making and to integrate Japanese evidence with broader international findings. The search period covered a 10-year span from April 2016 to March 2026, with the final search conducted in April 2026. The search strategy employed combinations of the following keywords:
Palliative and end-of-life care: “terminal care,” “hospice care,” “palliative care,” “end of life.”
Decision-making: “decision making,” “advance care planning (ACP),” “shared decision making (SDM),” “surrogate,” “proxy.”
Psychological and cultural factors: “regret,” “satisfaction,” “conflict,” “burden,” “Japan,” “culture,” “omakase.”
The synthesis was designed to identify decision-making processes and outcome-related patterns across international and Japanese bodies of literature, rather than to conduct a formal country-by-country comparative analysis.
Eligibility criteria
Studies were included based on the following criteria.
Population: Adult patients with advanced cancer (oncology focus) and their family members or surrogate decision-makers.
Content: Original research articles describing the decision-making process in end-of-life care.
Core elements: Studies were required to include both of the following:Element A, decision-making involvement: Descriptions of patient/family participation in decision-making or intentional delegation to others.
Element B, psychological outcomes: Specific evaluations of outcomes resulting from the decision, including psychological (satisfaction, regret, conflict, distress), clinical (aggressiveness of care), or economic outcomes (financial toxicity, healthcare resource utilization).
Exclusion criteria: We excluded editorials, letters to the editor, case reports, and protocol papers without published results. General literature reviews were excluded. However, one Cochrane review was retained as an exception because it contained evidence directly relevant to interpersonal communication in EOL care, which was a central decision-support process examined in this review.
Selection and screening process
A three-stage relevance screening process was used to ensure that included studies addressed both EOL decision-making involvement and psychological outcomes.
First stage, title screening
From 1813 records initially identified through database searching (PubMed: 1,136; Ichushi-Web: 677), 1076 records remained after duplicate removal and initial document-type screening. A total of 741 records were excluded because they did not match the target population or did not address EOL decision-making.
Second stage, abstract/summary screening
The remaining 335 records were assessed for the presence of both Element A and Element B; 105 records were excluded, primarily due to a lack of psychological outcome evaluations (n = 72).
Third stage (full-text/final summary assessment)
A total of 230 records underwent full-text or final summary assessment. At this stage, studies were retained if they met both final relevance conditions: they described a specific EOL decision-making scene, and they reported extractable statistical or qualitative findings related to psychological outcomes. These conditions were used to determine relevance to the review question, not to perform a formal quality or risk-of-bias assessment. Ultimately, 136 studies were selected for final analysis (Fig. 1). All 136 studies were included in the narrative synthesis; no smaller subset was analyzed separately. The complete matrix detailing the characteristics, decision contexts, and key outcomes of all 136 included studies is provided in Supplementary Table S1.
Data extraction and synthesis
From the 136 included studies, we extracted fundamental characteristics, including publication year, study design, target population, and specific decision-making topics.
A narrative synthesis was then conducted, focusing on three major themes.
The impact of delegation (leaving decisions to others) on psychological outcomes.
Mechanisms by which SDM and active involvement contribute to reducing regret and increasing satisfaction.
Determinants of satisfaction rooted in the Process itself (e.g., information transparency, value validation) rather than just medical results.
This analytical approach allowed us to identify the mechanism of the “decision vacuum” caused by insufficient support and to construct the framework for “prepared delegation” as a culturally sensitive model for end-of-life care. Consistent with the purpose of a scoping review, which was to map and synthesize the available evidence rather than to grade the certainty of effects, we did not conduct a formal risk-of-bias or methodological-quality assessment for all included records.
Results
Study selection
From the 1,813 records initially identified through database searching, 1,076 records remained after removing duplicates and limiting the search to original research articles. Following the three-stage relevance screening process, a total of 136 studies were selected for narrative synthesis (Fig. 1). These included 80 quantitative studies, 46 qualitative studies, 9 mixed-methods studies, and 1 Cochrane review focused on interpersonal communication in EOL care [13].
Characteristics of included studies
The 136 included studies were published between 2016 and 2026, with a significant surge in research activity from 2024 to 2026, accounting for 46 papers (33.8%). The research designs were predominantly quantitative (58.8%), though qualitative studies were also abundant (33.8%) [14]. Study populations were evenly distributed among patients (33.8%), family members/surrogates (33.8%), and patient-family dyads (32.4%). The primary decision-making topics were advance care planning (ACP) (24.3%) and end-of-life care (22.8%) [15] (Table 1).
Table 1Characteristics of the 136 included studies. This table summarizes the foundational characteristics of the 136 studies included in this review, categorized by publication year, study design, target population, and specific decision-making topics. It highlights the recent surge in research activity (2024–2026) and a balanced distribution of focus between patients and family surrogates, reflecting the growing trend toward viewing end-of-life decision-making as a family-centered process
Characteristic Category Number (n) Percentage (%)
1. Publication year 2016–2020 53 39.0%
2021–2023 37 27.2%
2024–2026* 46 33.8%
(Total) 136 100.0%
2. Study design Quantitative 80 58.8%
Qualitative 46 33.8%
Mixed methods 9 6.6%
Others (e.g., cochrane review) 1 0.7%
3. Target population Patients only 46 33.8%
Family/surrogate decision-makers only 46 33.8%
Both patients and families (including dyads) 44 32.4%
4. Decision-making topics ACP/future preparedness 33 24.3%
EOL care/palliative care (e.g., sedation, CPR) 31 22.8%
Cancer treatment choice (e.g., chemotherapy) 15 11.0%
Care setting/discharge planning 9 6.6%
Others (e.g., SDM general, family meetings) 48 35.3%
*Data for 2026 is updated as of May 2026
Decision-making styles and psychological outcomes
Impact of delegation and exclusion
Delegating decisions to physicians or being excluded from the process was strongly associated with negative psychological states. Specifically, physician-led decisions for care settings resulted in significantly higher decisional regret scores among bereaved families compared to shared decision-making (SDM) (ρ = − 0.400, P < 0.001) [16]. Furthermore, when physicians acted as the sole decision-makers, families’ evaluations of the patient’s Quality of Life (QOL) were significantly lower than in other styles (P = 0.014) [17]. Our synthesis of qualitative data revealed that families excluded from the process often felt like “pawns in an unclear pathway” [18, 19], with 71% expressing dissatisfaction due to the “lack of inclusion” [18].
Contribution of shared decision-making
Active participation significantly bolstered decisional certainty. A randomized trial of SDM for code status discussions demonstrated a reduction in decisional uncertainty by 7.06 points on the Decisional Conflict Scale [20]. Qualitatively, SDM fostered “post-bereavement self-growth”; families who made difficult choices together with patients later looked back on the caregiving experience as fulfilling, with some even stating, “it was fun” [14]. This commitment to the caregiving role through shared choice facilitated a sense of “life completion” and growth [21, 22].
Importance of process quality
The quality of the interaction—specifically the validation of values—governed long-term outcomes. Clinicians’ failure to validate what patients and families prioritized left survivors with a lasting “psychological weight” [5]. In contrast, a continuous relationship with a case manager or nurse who explored values allowed patients to feel “safe to entrust” their care, even when they did not seek full individual autonomy [23, 24].
Determinants of satisfaction and regret by topic
Treatment selection
The communication style during the cessation of therapy was critical. In Japan, failing to explain the specific benefits of discontinuation (e.g., maintaining dignity and QOL) was a significant predictor of family dissatisfaction with the physician’s explanation (β = 0.228, P = 0.001) [25]. When families perceived EOL care as too aggressive (AOC), they reported significantly higher decisional regret (Cohen’s d = 0.49) [26]. Additionally, qualitative evidence indicates that approximately 40% of bereaved families experience regret regarding treatment cessation, which is primarily attributed to the quality of the decision-making process and the nature of their relationship with healthcare providers [27].
Choice of care setting
Discordance between preferred and actual place of death (POD) intensified depression and grief among bereaved families [28, 29]. A pivotal finding in the Japanese context was that the clinical guarantee of a “back-bed” (a secured hospital bed for emergency admission) served as a critical “turning point” that supported family peace of mind and the decision for home death [30].
End-of-life procedures
Regarding clinical procedures, evidence from Japanese studies (Ichushi-Web) highlighted that surrogate decisions regarding sedation or DNR when patient preferences were unknown caused intense ambivalence and guilt in 41% of cases. Conversely, synthesized international studies (PubMed) demonstrated that the “informed assent” approach successfully reduced surrogate psychological burden during code-status conversions [31] (Table 2).
Table 2Factors associated with satisfaction and decisional regret by decision-making topic. This table categorizes the key determinants of psychological outcomes identified from the included studies, focused on three major clinical domains: (1) treatment choice, (2) selection of care settings, and (3) end-of-life clinical procedures. It distinguishes between factors that foster clinical consensus and satisfaction (e.g., prior validation of values, guarantee of a “back-bed”) and those that trigger long-term decisional regret (e.g., aggressiveness of care, discordance in preferences)
Decision-making topic Factors leading to satisfaction/consensus ID Factors leading to regret/dissatisfaction ID
1) Treatment choice ・Explanation of specific benefits of discontinuation (e.g., maintenance of QOL) 25 (Int), 27 (J) ・Aggressiveness of care (AOC) through inappropriate life-sustaining treatments 4 (Int), 26 (Int)
・Sharing future quality of life (QOL) predictions 33 (Int) ・Neglect of emotional reactions to treatment side effects 34 (Int)
2) Choice of care setting ・Prior validation of patient values and preferences regarding the place of care 5 (J), 35 (Int) ・Discordance between preferred and actual place of death 28 (J), 29 (int)
・Guarantee of a “back-bed” (secured hospital bed for emergency readmission) 30 (J) ・Pressured decisions driven by system constraints (e.g., discharge deadlines) 36 (J)
3) End-of-life procedures (e.g., sedation) ・Use of “informed assent” approach to reduce the psychological burden of active decision-making 32 (Int) ・Surrogate decisions made when the patient’s preferences are unknown 31 (J)
・Application of shared decision-making (SDM) to clarify code status 20 (Int), 37 (Int) ・Physician-led (paternalistic) decisions excluding patients and families from the process 16 (Int), 17 (J)
*J Japanese literature (Ichushi-Web), Int International English literature (PubMed)
Effective decision-support intervention methods
Digital and media interventions
Digital tools effectively reduced subjective uncertainty. The use of a video ACP tool significantly decreased decisional uncertainty from 28.3 to 21.7 (P = 0.02) [32] and was rated as “very helpful” by 85% of users [33]. Furthermore, mobile apps for recording consultations allowed 77% of patients to review information at home, which directly improved their knowledge and confidence in treatment selection [34].
Interpersonal and dialogue interventions
Structured communication led by nurses achieved remarkably high satisfaction. For instance, a specific emergency-department study on nurse-directed Goals-of-Care discussions reported 95–100% patient satisfaction scores [35]. Overall, multi-center international and Japanese data confirm that specialist palliative care team involvement significantly improves care satisfaction (SMD 0.36) and increases home death rates (OR 1.63) [36, 37].
Impact of timing
The timing of support determines the presence of the “decision vacuum.” Proactive, phased interventions from the early palliative stage fostered “future preparedness” (r = 0.38) [38, 39]. In contrast, decisions forced in “crisis phases”—such as immediately after an emergency admission—triggered confusion and long-term regret, as families were unprepared for the “sudden race to the end” [40, 41] (Table 3).
Table 3Effective intervention methods and success factors in decision support. This table summarizes evidence-based intervention strategies classified into digital/media, interpersonal/dialogue, and mindfulness-based categories. It highlights the specific functional mechanisms of each approach—such as promoting information understanding and eliciting deep-seated values—and identifies the optimal clinical timing to maximize patient and caregiver preparedness throughout the illness trajectory
Intervention category Specific methods Key functions and timing ID
1) Digital/media intervention Video ACP tools, Web-based Decision Aids (DA), Consultation recording apps [Function] Promoting information understanding, reducing decisional uncertainty 38 (Int), 39 (Int), 40 (Int)
[Timing] From diagnosis to treatment selection (Early phase)
2) Interpersonal/dialogue intervention Nurse coaching, Multidisciplinary conferences, CNS coordination [Function] Eliciting patient values, mediating intent-discordance within families 43 (int), 47 (J), 48 (J)
[Timing] From symptom worsening to end-of-life (Mid-to-late phase)
3) Mindfulness Emotional control, reducing psychological barriers [Function] Mitigating fear of death, psychological preparation for ACP 49 (Int)
[Timing] Throughout the illness trajectory post-diagnosis
*J Japanese literature (Ichushi-Web), Int International English literature (PubMed)
Discussion
This scoping review synthesized findings from 136 studies to clarify how process quality influences psychological and economic outcomes in cancer EOL decision-making [13].
A central contribution of this synthesis is the demonstration that the formal decision-making style—whether autonomy-based or delegation-based—does not intrinsically dictate outcome quality. Rather, our synthesis demonstrates that delegation itself is not inherently problematic. Negative outcomes (such as severe decisional regret, = − 0.400 [16], and downstream financial toxicity) arise when delegation occurs within an unprepared “decision vacuum,” where patient values remain unarticulated, and decisions are dictated by medical paternalism or system constraints (Figs. 2 and 3). Conversely, when delegation is preceded by value validation and trust-building (“prepared delegation”), it yields high satisfaction and low regret for both patients and bereaved surrogates.
Clinical and economic harms of the “decision vacuum”
Our definition of the “decision vacuum”—a state in which external drivers such as hospital bed shortages or medical paternalism dictate care due to unarticulated patient values frames this absence of preparation as a clinically important process gap. The synthesized literature suggests that this vacuum is often exacerbated by a lack of accurate prognostic alignment [42] and unaddressed emotional responses to treatment-related outcomes [43], both of which are identified as significant contributors to downstream psychological, clinical, and economic burdens [9–12].
Behavioral and economic consequences
When standard therapy ceases without adequate preparation, families often lose their decisional anchors, leading to an increased reliance on non-evidence-based therapies [9]. This is not merely a medical choice but a manifestation of psychological vulnerability, often triggering financial toxicity that may threaten family economic stability during bereavement and after the patient’s death [9, 10].
Medical consequences
Surrogate decisions made without prior value validation frequently result in inappropriate aggressiveness of Care (AOC) [4, 26], characterized by high-intensity life-sustaining treatments. Our synthesis found that such decisions were associated with increased ICU utilization and escalating medical costs [11, 12], suggesting that a “decision vacuum” compromises both individual dignity and the equitable allocation of healthcare resources.
Reconstructing Japanese-style ACP: “prepared delegation”
Across the included literature, delegation should not be interpreted only as passive abandonment of autonomy. In Japanese and East Asian contexts, delegation often reflects an active, relational choice rooted in trust and family harmony. Our synthesis strongly aligns with the recent Asian consensus on ACP, which emphasizes that advance care planning in Asian sectors must accommodate family-centered decision-making and relational autonomy [6, 7].
Crucially, this review demonstrates that barriers to EOL decision-making are not unique to Asian settings. Prognostic uncertainty, emotional avoidance, and family discordance frequently compromise ACP in Western settings where individual autonomy is prioritized [19, 44]. Therefore, the “prepared delegation” model—driven by continuous value validation, information transparency, and multidisciplinary coordination—offers a process-oriented framework. While particularly tailored to settings with relational delegation like Japan, it provides universal insights for transforming unsupported delegation into a value-concordant, high-quality decision process across diverse healthcare systems:
Continuous validation of values
Clinicians’ repeated confirmation of priorities serves as a “buffer” that mitigates the “psychological weight” and regret [5, 23, 24, 45].
Information transparency
Visualizing future options through video ACP tools improves subjective certainty, reducing uncertainty scores from 28.3 to 21.7 (P = 0.02) [32, 33, 46].
Multidisciplinary coordination
Professional mediation by nurses or specialists to resolve intent-discordance within families is essential to reach a consensus [30, 37, 47, 48].
“Prepared delegation” may provide a clinically useful framework for cancer EOL decision support in settings where patients and families prefer relational or delegated decision-making. Rather than serving as a universal standard, this model should be understood as a process-oriented approach that requires further evaluation across different diseases, care systems, and cultural contexts.
Practical guidelines: informed assent and timing
Mitigating surrogate burden
Decisions regarding DNR or sedation when preferences are unknown often cause intense ambivalence and guilt, with families fearing they are “shortening the patient’s life” [41, 49]. The “informed assent” approach—where clinicians propose the best care and families authorize it—was found to be “acceptable” to most, effectively relieving families of the “weight of decision-making” [31]. This is further supported by findings that providing specific clinical recommendations, rather than leaving the decision entirely to families, is an acceptable communication style that significantly reduces the burden of surrogate decision-making in palliative care [50].
The importance of timing
While nurse-led dialogues achieved high satisfaction (95%–100%) due to timely implementation [35], decisions made in the “crisis phase”—such as immediately after an emergency admission—accelerated confusion and regret (ρ = − 0.400) [16]. In the Japanese oncology context, the clinical guarantee of a “back-bed,” or emergency readmission option, may provide the reassurance needed for some families to consider home-based care [30]. However, this support mechanism may not be available or function similarly in other health care systems, and its applicability should therefore be interpreted within the specific care context in which it was reported.
Limitations
This study is subject to several limitations characteristic of its design. First, because this was a scoping review, we did not conduct a formal risk-of-bias or methodological-quality assessment of the 136 included studies. Therefore, the findings should be interpreted as a narrative mapping of available evidence rather than as a graded assessment of intervention effectiveness or evidence certainty. Second, although the inclusion of Ichushi-Web allowed the review to incorporate Japanese evidence and reduce reliance on English-language literature, the search was limited to PubMed and Ichushi-Web and may have excluded relevant studies indexed in other international or regional databases. In addition, many included studies described decision-making within individual countries or care settings rather than directly comparing Japan with other regions; therefore, cross-cultural interpretations should be understood as synthesized patterns rather than formal comparative conclusions. Third, the review focused primarily on oncology and cancer EOL decision-making. Therefore, the findings, including the proposed “prepared delegation” model, should be generalized cautiously to non-cancer illnesses, pediatric or non-oncology palliative care, acute-care decision-making, and health care systems with different family, legal, or institutional structures.
Conclusion
In cancer EOL decision-making, decision support should move beyond a simple dichotomy between individual autonomy and delegation and instead focus on reducing the “decision vacuum” through improved process quality. The proposed “prepared delegation” model may help support value-concordant decision-making by emphasizing early preparation, information transparency, value validation, and multidisciplinary coordination.
Supplementary information
Below is the link to the electronic supplementary material.
Author contributions
SK and MK conceived the study. SK and MK conducted the literature search and study selection. SK, MK, and YI performed data extraction and analysis. SK and MK drafted the manuscript, and all authors critically revised it. All authors approved the final manuscript.
Funding
Open Access funding provided by The University of Tokyo.
Data availability
No datasets were generated or analysed during the current study.
Declarations
Ethics approval
Ethics approval was not required because this study reviewed previously published literature and did not involve human participants.
Competing interests
The authors declare no conflicts of interest.
Footnotes
Key message
• This scoping review demonstrates that process quality in EOL decision-making is a critical determinant of long-term outcomes for cancer survivors and bereaved families. We introduce the “prepared delegation” model—emphasizing early value validation and multidisciplinary coordination—as a clinical framework to eliminate “decision vacuums,” thereby mitigating persistent decisional regret and financial toxicity in oncology settings.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
1.Park S, Yu SY (2026) Healthcare utilization and end-of-life care based on life-sustaining treatment decisions in patients with cancer. Support Care Cancer 34(4):363
2.Yang CH, Wu CY, Cheng SY et al (2025) Reasons for and congruence between preferred and actual place of death among cancer patients receiving end-of-life care: a cross-cultural multicenter prospective cohort study in East Asia. Cancers (Basel) 17(13):2062
3.Groenewoud AS, Sasaki N, Westert GP, Imanaka Y (2020) Preferences in end-of-life care substantially differ between the Netherlands and Japan: results from a cross-sectional survey study. Medicine (Baltimore) 99(44):e22743
4.Wen FH, Hsieh CH, Su PJ, Shen WC, Hou MM, Chou WC, Chen JS, Chang WC, Tang ST (2024) Factors associated with family surrogate decisional-regret trajectories. J Pain Symptom Manage 67(3):223-232.e2. 10.1016/j.jpainsymman.2023.11.013
5.Yamamoto S, Arao H (2018) Factors related to family’s burden in the decision-making process for the place of end-of-life care for patients with terminal cancer: a study from J-HOPE3. Gan No Kango 23(1):58–61 (IchusiID: 2018215297 (in Japanese))
6.Mori M, Chan HYL, Lin CP, Kim SH, Ng Han Lip R, Martina D, Yuen KK, Cheng SY, Takenouchi S, Suh SY, Menon S, Kim J, Chen PJ, Iwata F, Tashiro S, Kwok OLA, Peng JK, Huang HL, Morita T, Korfage IJ, Rietjens JAC, Kizawa Y (2025) Definition and recommendations of advance care planning: a Delphi study in five Asian sectors. Palliat Med 39(1):99–112. 10.1177/02692163241284088
7.Martina D, Geerse OP, Lin CP, Kristanti MS, Bramer WM, Mori M, Korfage IJ, van der Heide A, Rietjens JA, van der Rijt CC (2021) Asian patients’ perspectives on advance care planning: a mixed-method systematic review and conceptual framework. Palliat Med 35(10):1776–1792. 10.1177/02692163211042530
8.Fujimoto M, Koffman J, Nagata I, Sakaguchi Y, Evans CJ (2025) Palliat Care Soc Pract 28(19):26323524251395656. 10.1177/26323524251395654
9.Olson RE, Smith A, Good P, Dudley M, Gurgenci T, Hardy J (2023) ‘What price do you put on your health?’: medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer. Health Expect 26(1):160–171. 10.1111/hex.13642
10.Chua CK, Wu JT, Wong YY, Qu L, Tan YY, Neo PS, Pang GS (2016) Caregiving and its resulting effects-the care study to evaluate the effects of caregiving on caregivers of patients with advanced cancer in Singapore. Cancers (Basel) 8(11):105. 10.3390/cancers8110105
11.Wen FH, Chiang MC, Huang CC, Hu TH, Chou WC, Chuang LP, Tang ST (2024) Quality of dying and death in intensive care units: family satisfaction. BMJ Support Palliat Care 13(e3):e1217–e1227. 10.1136/spcare-2022-003950
12.Chan KY, Chiu HY, Yap DYH, Li CW, Yip T, Tsang KW, Tam WO, Au HY, Wong CY, Chan ML, Sham MK (2021) Impact of structured advance care planning program on patients’ wish items and healthcare utilization. Ann Palliat Med 10(2):1421–1430. 10.21037/apm-20-589
13.Ryan RE, Connolly M, Bradford NK, Henderson S, Herbert A, Schonfeld L, Young J, Bothroyd JI, Henderson A (2022) Interventions for interpersonal communication about end of life care between health practitioners and affected people. Cochrane Database Syst Rev 7(7):CD013116. 10.1002/14651858.CD013116.pub2
14.Tsukamoto R (2023) “It was fun,” said the family about home terminal care. Best Nurse 34(1):50–53 (IchusiID: 2023065810 (in Japanese))
15.Ogata Y, Okada M, Kunugi N et al (2017) Caregiving experiences of spouses who provided satisfying home-based end-of-life care for terminally ill cancer patients. Nihon Chiiki Kango Gakkai Shi 20(2):64–72 (IchusiID: 2018026895 (in Japanese))
16.Okimura A, Hayashi N (2022) Relationships between bereaved families’ decision-making regret about end-of-life care place for patients with cancer and relevant factors. Asia Pac J Oncol Nurs 10(1):100167. 10.1016/j.apjon.2022.100167
17.Iwabuchi M, Sato K, Miyashita M et al (2016) Factors that influence the decision maker regarding end-of-life care. Palliative Care Research 11(2):189–200. 10.2512/jspm.11.189
18.Augustussen M, Hounsgaard L, Pedersen ML, Sjøgren P, Timm H (2017) Relatives’ level of satisfaction with advanced cancer care in Greenland - a mixed methods study. Int J Circumpolar Health 76(1):1335148. 10.1080/22423982.2017.1335148
19.Chien CY, Kuo LT, Lin CP (2025) Exploring the perspectives of early-stage postoperative glioblastoma patients and their caregivers on end-of-life care planning: an exploratory qualitative interview study. Appl Nurs Res 81:151897. 10.1016/j.apnr.2024.151897
20.Becker C, Gross S, Beck K, Amacher SA, Vincent A, Mueller J, Loretz N, Blatter R, Bohren C, Urben T, Arpagaus A, Schaefert R, Schuetz P, Kaegi-Braun N, Stalder L, Leuppi JD, Aujesky D, Baumgartner C, Hug B, Schmieg H, Delfine V, Peters T, Templeton AJ, Bassetti S, Hunziker S (2025) A randomized trial of shared decision-making in code status discussions. NEJM Evid 4(5):EVIDoa2400422.
10.1056/EVIDoa2400422
21.Mori M, Onishi C, Imai Y et al (2020) Stress and coping of family caregivers providing home care for terminal cancer patients with difficult pain control. Shikoku Igaku Zasshi 76(5–6):279–290 (IchusiID: 2021193138 (in Japanese))
22.Bakitas M, Dionne-Odom JN, Jackson L, Frost J, Bishop MF, Li Z (2017) “There were more decisions and more options than just yes or no”: evaluating a decision aid for advanced cancer patients and their family caregivers. Palliat Support Care 15(1):44–56. 10.1017/S1478951516000596
23.Noguchi S (2020) Potential of home-based life support in nurse-led multifunctional small-scale domiciliary care: as decision-making support for end-of-life cancer patients and their families. Bukkyodaigaku Daigakuin Kiyo 48:35–52 (IchusiID: 2020228343 (in Japanese))
24.Putker A, Perry M, Chalkiopoulos J, Piek A, Engels Y, Kuip E (2025) Casemanagers positioned as key advance care planning conversationalists in oncology care: a qualitative interview study on the perspectives of healthcare professionals and patients. Cancer Med 14(17):e71195. 10.1002/cam4.71195
25.Yoshida S, Hirai K, Ohtake F, Masukawa K, Morita T, Kizawa Y, Tsuneto S, Shima Y, Miyashita M (2024) Preferences of bereaved family members on communication with physicians when discontinuing anticancer treatment: referring to the concept of nudges. Jpn J Clin Oncol 54(7):787–796. 10.1093/jjco/hyae038
26.Tönnies J, Hartmann M, Jäger D, Bleyel C, Becker N, Friederich HC, Haun MW (2021) Front Oncol 4(11):673147. 10.3389/fonc.2021.673147
27.Shiozaki M, Sanjo M, Yoshida S et al (2017) Regret and psychological coping of bereaved families regarding decision-making to discontinue treatment in the terminal stage: what and why do families regret about treatment discontinuation? Palliat Care Res 12(4):753–760 (IchusiID: 2018155105 (in Japanese))
28.Shuto M (2018) Factors emphasized when deciding the place of care and the agreement between the preferred and actual place of care: a study from J-HOPE3. Gan No Kango 23(1):55–57 (IchusiID: 2018215296 (in Japanese))
29.Bannon F, Cairnduff V, Fitzpatrick D, Blaney J, Gomes B, Gavin A, Donnelly C (2018) Insights into the factors associated with achieving the preference of home death in terminal cancer: a national population-based study. Palliat Support Care 16(6):749–755. 10.1017/S1478951517000876
30.Hayashi M, Numata T, Kamioka A (2020) Support that influenced the turning point when the family of a terminal cancer patient decided on home discharge: analysis of family support using the Watanabe family assessment model. Iwamizawa Shiritsu Sogo Byoin Ishi 46(1):35–39 (IchusiID: 2020362381 (in Japanese))
31.Stapleton RD, Ford DW, Sterba KR, Nadig NR, Ades S, Back AL, Carson SS, Cheung KL, Ely J, Kross EK, Macauley RC, Maguire JM, Marcy TW, McEntee JJ, Menon PR, Overstreet A, Ritchie CS, Wendlandt B, Ardren SS, Balassone M, Burns S, Choudhury S, Diehl S, McCown E, Nielsen EL, Paul SR, Rice C, Taylor KK, Engelberg RA (2022) Evolution of investigating informed assent discussions about CPR in seriously ill patients. J Pain Symptom Manage 63(6):e621–e632. 10.1016/j.jpainsymman.2022.03.009
32.Dharmarajan KV, Walters CB, Levin TT, Milazzo CA, Monether C, Rawlins-Duell R, Tickoo R, Spratt DE, Lovie S, Giannantoni-Ibelli G, McCormick B (2019) A video decision aid improves informed decision making in patients with advanced cancer considering palliative radiation therapy. J Pain Symptom Manage 58(6):1048-1055.e2. 10.1016/j.jpainsymman.2019.08.014
33.Aslakson RA, Isenberg SR, Crossnohere NL, Conca-Cheng AM, Moore M, Bhamidipati A, Mora S, Miller J, Singh S, Swoboda SM, Pawlik TM, Weiss M, Volandes A, Smith TJ, Bridges JFP, Roter DL (2019) Integrating advance care planning videos into surgical oncologic care: a randomized clinical trial. J Palliat Med 22(7):764–772. 10.1089/jpm.2018.0209
34.Kwon DH, Trihy L, Darvish N, Hearst E, Sumra S, Borno HT, Bose R, Chou J, de Kouchkovsky I, Desai A, Ekstrand B, Friedlander T, Kaur G, Koshkin VS, Nesheiwat S, Sepucha K, Small EJ, Aggarwal RR, Belkora J (2024) Patients can administer mobile audio recordings to increase knowledge in advanced prostate cancer. Cancer Med 13(22):e70433. 10.1002/cam4.70433
35.Bigelow S, Medzon R, Siegel M, Jin R (2024) Difficult conversations: outcomes of emergency department nurse-directed goals-of-care discussions. J Palliat Care 39(1):3–12. 10.1177/08258597221149402
36.Bajwah S, Oluyase AO, Yi D, Gao W, Evans CJ, Grande G, Todd C, Costantini M, Murtagh FE, Higginson IJ (2020) The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 9(9):CD012780. 10.1002/14651858.CD012780.pub2
37.Oluyase AO, Higginson IJ, Yi D, Gao W, Evans CJ, Grande G, Todd C, Costantini M, Murtagh FEM, Bajwah S (2021) Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review. Southampton (UK): NIHR J Libr
38.Tan AJQ, Low ESQY, Yu K, Natesan N, Yeo SM, Kok HSC, Bakitas M, Odom JN, Yang GM (2025) Patient and caregiver perspectives on a coaching-based early palliative care program (enable, nurture, advise, before life ends for Singapore): a qualitative study. J Palliat Med 28(10):1332–1339. 10.1177/10966218251365263
39.Van Scoy LJ, Levi BH, Witt P, Bramble C, Richardson C, Putzig I, Levi AR, Wasserman E, Chinchilli V, Tucci A, Green MJ (2020) Association of participation in an end-of-life conversation game with advance care planning behavior and perspectives among African American individuals. JAMA Netw Open 3(5):e204315. 10.1001/jamanetworkopen.2020.4315
40.Mochizuki K (2022) Decision-making support for terminal esophageal cancer patients and their families in a general ward: reflecting with the bereaved family. Fukuoka Sekijuji Kango Kenkyukai Shuroku 36:44–47 (IchusiID: 2022230370 (in Japanese))
41.Lee JT, Mittal DL, Warby A, Kao S, Dhillon HM, Vardy JL (2022) Dying of mesothelioma: a qualitative exploration of caregiver experiences. Eur J Cancer Care (Engl) 31(5):e13627. 10.1111/ecc.13627
42.Hoerger M, Gramling R, Epstein R, Fenton JJ, Mohile SG, Kravitz RL, Mossman B, Prigerson HG, Alonzi S, Malhotra K, Duberstein P (2022) Patient, caregiver, and oncologist predictions of quality of life in advanced cancer: accuracy and associations with end-of-life care and caregiver bereavement. Psychooncology 31(6):978–984. 10.1002/pon.5887
43.Visser S, de Mol M, Cheung K, van Toor JJ, van Walree NC, Stricker BH, Den Oudsten BL, Aerts JGJV (2018) Treatment satisfaction of patients with advanced non-small-cell lung cancer receiving platinum-based chemotherapy: results from a prospective cohort study (PERSONAL). Clin Lung Cancer 19(4):e503–e516. 10.1016/j.cllc.2018.03.003
44.Johns SA, Beck-Coon K, Stutz PV, Talib TL, Chinh K, Cottingham AH, Schmidt K, Shields C, Stout ME, Stump TE, Monahan PO, Torke AM, Helft PR (2020) Mindfulness training supports quality of life and advance care planning in adults with metastatic cancer and their caregivers: results of a pilot study. Am J Hosp Palliat Care 37(2):88–99. 10.1177/1049909119862254
45.Kroon LL, van Roij J, Korfage IJ, Reyners AKL, van den Beuken-van Everdingen MHJ, den Boer MO, Creemers GJ, de Graeff A, Hendiks MP, Hunting JCB, de Jong WK, Kuip EJM, van Laarhoven HWM, van Leeuwen L, van Lindert ASR, Mandigers CMPW, Nieboer P, van der Padt-Pruijsten A, Smilde TJ, Sommeijer DW, Thijs MF, Tiemessen MA, Vos AH, Vreugdenhil A, Werner PT, van Zuylen L, van de Poll-Franse LV, Raijmakers NJH, eQuiPe study group (2021) Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer. J Cancer Surviv 15(3):380–385. 10.1007/s11764-021-01020-y
46.Hiratsuka Y, Nakazawa Y, Miyashita M, Morita T, Okumura Y, Kizawa Y, Kawagoe S, Yamamoto H, Takeuchi E, Yamazaki R, Ogawa A (2025) Impact of diagnosis nondisclosure on quality of dying in cancer patients: a bereavement study. J Pain Symptom Manage 69(2):196–203. 10.1016/j.jpainsymman.2024.10.036
47.Otake Y, Noguchi M, Nohara Y et al (2017) Decision-making support by a homecare nurse for a family with different views regarding the place for end-of-life care. Kazoku Kango Gaku Kenkyu 23(1):64–74 (IchusiID: 2018302651 (in Japanese))
48.Nakai N, Yamada R, Kitatani Y et al (2021) A study of the possible coordinations by the certified nurse specialist in cancer nursing for the terminal patients and their families who suffer the emotional discrepancies upon the choice of home terminal care. Kango Kea Saiensu Gakkai Shi 20(1):3–14 (IchusiID: 2022017281 (in Japanese))
49.Tada S, Asano M, Minoshima M et al (2016) Issues for pain relief of terminal cancer patients from the current status of continuous sedation in our hospital. Gifu Sekijuji Byoin Igaku Zasshi 27(1):25–28 (IchusiID: 2016337633 (in Japanese))
50.Nishioka M, Okuyama T, Uchida M, Aiki S, Ito Y, Osaga S, Imai F, Akechi T (2019) What is the appropriate communication style for family members confronting difficult surrogate decision-making in palliative care?: a randomized video vignette study in medical staff with working experiences of clinical oncology. Jpn J Clin Oncol 49(1):48–56. 10.1093/jjco/hyy178
Associated Data
Supplementary Materials
Data Availability Statement
No datasets were generated or analysed during the current study.
Come citare questo studio
Kuroda S, Iimura Y, Kuroda M. (2026). Decision vacuum and prepared delegation in cancer end-of-life decision-making: a scoping review.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. DOI: 10.1007/s00520-026-11394-3
Consulta la pubblicazione originale ↗